Suraksha Diagnostic
Mainboard₹14,994 / 34 Shares
Suraksha Diagnostic IPO Details
The Suraksha Diagnostic IPO price band is set between ₹420-441 per equity share, with a face value of ₹2 per share. The issue is managed by Kfin Technologies Limited, and the equity shares are proposed to be listed on the Mainboard.
The IPO date for subscription opens on 29 Nov, 2024 and closes on 3 Dec, 2024. Investors can check the allotment status on 4 Dec, 2024, while the listing date is tentatively scheduled for 6 Dec, 2024.
The total issue size is OFS : 19,189,330 shares of ₹2, aggregating up to ₹846.2 Crores. Stay tuned for the latest Suraksha Diagnostic IPO review and GMP updates.
Suraksha Diagnostic IPO Review, Rating & Analysis
Suraksha Diagnostic IPO Review
NO REVIEWSuraksha Diagnostic IPO Rating
Suraksha Diagnostic IPO Highlights
IPO Date
Nov 29, 2024 - Dec 3, 2024
Listing Date
6 Dec, 2024
Face Value
₹2 Per Equity Share
Price Band
₹420-441 per equity share
Lot Size
34 Shares
Fresh Issue
Shares
Offer for Sale
19,189,330 shares of ₹2
Listing At
BSE, NSE
Suraksha Diagnostic IPO Lot Size
The minimum market lot for Suraksha Diagnostic IPO is 34 shares with an application amount of ₹14,994. Retail investors can apply for up to 13 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 34 | ₹14,994 |
| Retail (Max) | 13 | 442 | ₹1,94,922 |
| S-HNI (Min) | 14 | 476 | ₹2,09,916 |
| S-HNI (Max) | 66 | 2244 | ₹9,89,604 |
| B-HNI (Min) | 67 | 2278 | ₹10,04,598 |
Suraksha Diagnostic IPO Timeline
Issue Price
₹420-441 per equity shareFace Value
₹2 Per Equity ShareListing at Group
BSE, NSERegistrar
Kfin Technologies LimitedLead Manager
ICICI Securities LimitedNuvama Wealth Management LimitedSBI Capital Markets LimitedIssue Size
OFS : 19,189,330 shares of ₹2(aggregating up to ₹846.2 Crores)Suraksha Diagnostic IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 24 | 300.21 | 222.26 | 23.13 | 179.41 | 170.88 | 8.64 |
| 31 Mar 23 | 281.20 | 193.69 | 6.07 | 155.93 | 147.40 | 14.01 |
| 31 Mar 22 | 275.96 | 225.77 | 20.82 | 145.84 | 137.31 | 19.03 |
All values are in ₹ Cr.
Suraksha Diagnostic IPO Valuations
EPS Pre IPO
₹4.44/-EPS Post IPO
₹5.89/-PE Pre IPO
99.31PE Post IPO
74.89ROE
14.09%ROCE
21.46%Debt Equity
0.20RoNW
14.09%PAT Margin
10.57Price to Book Value
13.10Promoters & Share Holding
Promoter(s) Name
- Dr. Somnath Chatterjee
- Ritu Mittal
- Satish Kumar Verma
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 61.07% | 48.78% |
About Company
On March 15, 2005, Suraksha Diagnostic Limited began its operation as a leading technology-driven diagnostic chain in India. The company provides integrated pathology, radiology, and medical consultancy services under one umbrella with an excellent operational network. As of date, more than 2,300 specialized tests in various disciplines of medicine meet diverse health needs.
Comprehensive Diagnostic Network:Suraksha Diagnostic runs a state-of-the-art central reference laboratory supported by 8 satellite laboratories and 194 customer contact points, including 48 diagnostic centers and 146 sample collection centers. This extensive infrastructure thus provides seamless patient experience, convenient and accessible across eastern and northeastern India.
Besides offering diagnostic services, over 120 polyclinics function in 43 diagnostic centers with more than 750 doctors across the organization to offer in-house medical consultations for improving patient care.
Suraksha Diagnostic IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 3,837,867 | 2,878,400 1,918,934 959,466 | 6,716,266 | 13,432,533 |
Day 1 -29-11-24 05:00 PM | 0.00 x | 0.04 0.02 x 0.08 x | 0.20 x | 0.11 x |
Day 2 -02-12-24 05:00 PM | 0.00 x | 0.13 0.08 x 0.23 x | 0.45 x | 0.25 x |
Day 3 -03-12-24 05:00 PM | 1.74 x | 1.40 1.53 x 1.16 x | 0.94 x | 1.27 x |
Retail:0.74x
BHNI:0.21x
SHNI:1.05x times
Company Contact Details
Suraksha Diagnostic
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327, New Town, Rajarhat Kolkata 700 156Registrar Contact Details
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: sdl.ipo@kfintech.com
Frequently Asked Questions about Suraksha Diagnostic IPO
When will Suraksha Diagnostic IPO open for subscription?
The Suraksha Diagnostic IPO opens on 29 Nov, 2024 and closes on 3 Dec, 2024.
What is the investors portion for Suraksha Diagnostic IPO?
The investors' portion for QIB is 1.74 x, NII is 1.53 x, and Retail is 0.94 x.
How to apply for Suraksha Diagnostic IPO?
You can apply for Suraksha Diagnostic IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Suraksha Diagnostic IPO?
The issue size of Suraksha Diagnostic IPO is approx ₹OFS : 19,189,330 shares of ₹2(aggregating up to ₹846.2 Crores) crores.
What is the price band of Suraksha Diagnostic IPO?
The price band for Suraksha Diagnostic IPO is ₹420 to ₹441 per equity share.
What is the lot size of Suraksha Diagnostic IPO?
The minimum bid (lot size) for Suraksha Diagnostic IPO is N/A shares with an investment of approx ₹14,994 .
What is the allotment date of Suraksha Diagnostic IPO?
The allotment date for Suraksha Diagnostic IPO is 4 Dec, 2024.
What is the listing date of Suraksha Diagnostic IPO?
The listing date for Suraksha Diagnostic IPO is expected to be 6 Dec, 2024.
What is the GMP of Suraksha Diagnostic IPO?
The latest Grey Market Premium (GMP) for Suraksha Diagnostic IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.